HOME
 SUMMARY
 PURPOSE
 INTERVIEWED
 STUDY
 PROTOCOL
 PERSONNEL
 MANUFACTURE
 MIXTURES
 BLENDING
 ANIMALS
 ANTE-MORTEM
 DOSAGE
 ORGANS
 DISEASES
 SURVIVAL
 ANALYSIS
 PATHOLOGY
 MICROSCOPIC
 CHARTS
SEND E-MAIL TO THE ASPARTAME SUPPORT GROUP
VISIT THE ASPARTAME SUPPORT GROUP WEBSITE
 PERSONS INTERVIEWED

PERSONS INTERVIEWED

Credentials were shown and a written Notice of Inspection was issued to Dr. William M. Merino, Directory, Domestic Pharmaceutical Products, Regulatory Affairs Department on April 25, 1977.  The following Searle personnel were present at the initial meeting on 4-25-1977.

 Robert A. Moe, PhD. - Executive Vice-President

 George Clay, PhD. - Group Leader, CNS Pharmacology

 Robert Bost, PhD. - Director of Food Products, Regulatory Affairs

 Holly Ru Probst - Director, Corporation Information Management Group.

 Dave Britton - Director Corporation Information  Department

 William Merino, PhD. - Director, Domestic Pharmaceutical Products

 Richard Viktora - Attorney

 James Phelps - Vice-President, General Counsel

 Elwood H. Ensor, PhD. - Vice-President

 Paul Klimstra, PhD. - Vice-President Pre-Clinical Research and Development

 Roger Thies - Attorney

During the course of our investigation one or more of the following Searle personnel were present in the Conference Room which we used for our data review.

   Richard Viktora - Attorney

   Roger Thies - Attorney

   George Clay, PhD. - Group Leader, CNS Pharmacology

   Robert Bost, PhD. - Director of Food Products Regulatory affairs

   Don Cook, PhD. - Associate Director, Department of Bio Research

   Dick Aspinol, PhD. - I. I. D. Group Leader

   Bill Jenkins, PhD. - Director, Product Affairs

   Fred McIlreath, PhD. - Director, Regulatory Affairs

   Paul Landefeld, - Attorney

Most of the time one attorney (R. Viktora or R. Thies) and one scientist were present.  During our initial meeting with Searle personnel, James Phelps stated that a Searle monitor must be with us at all times during our data review in order to "protect the data".

During the course of our investigation, various individuals were interviewed in an attempt to obtain all available raw data and reconstruct the manner in which the study was conducted, as accurately as possible.  Since many employees involved in the study or support areas are no longer employed at Searle, others were interviewed who had general knowledge of such parameters as statistics and chemistry.

Significant interviews are attached as Exhibits, as referenced. Individuals interviewed were as follows:

1.  Donna Helms - Administrative Assistant to Dr. McConnell on 5-18-77, 6-30-77 and 7/1/77 (Exh.  #46).

2.  Judith Beauchamp - Hematology Lab Supervisor on 6-2-77 (Exh. #47).

3.  Barbara Bickford (Nee Ross) - Technician, Department of Analytical Research on 6-1-77 and 6-2-77 (Exh. #48).

4.  Clifford J. Suel - Supervisor, Department of Analytical Research and Development on 6-2-77 (Exh. #49).

5.  Bartolome R. Tangonan - Research Technician, Pathology Toxicology Department on 6-1-77 (Exh. #50).

6.  Tony Martinez - Research Assistant and Toxicology Lab Supervisor on 5-19-77, 6-3-77, 7-7-77, 7-20-77 and 8-2-77 (Exh. #51).

7.  Ted Reichert - Supervisory Systems Analyst on 5-24-77 (Exh. #52).

8.  Phil Polli - Systems Analyst on 5-24-77 (Exh. #53).

9.  Judith Schmal - Clinical Chemistry Section Supervisor on 6-2-77 and 6-7-77 (Exh. #54).

10. Jane Drury - Analytical Chemist, Bioanalytical Dept. 6-7-77.

11. Alan Mitchell - Teratologist on 7-20-77 (Exh. #56).

12. Raymond G. Schroeder - Former Searle Teratologist on 7-18-77 (Exh. #57).

13. Dr. Rudolph Stejskal - Pathologist on 6-23-77.

14. Patricia Erdenberger - Research Assistant and Histopathology Lab Supervisor on various dates (Exh. #58).

Dr. Robert McConnell, Pathology-Toxicology Advisor at the time of this study, was not directly involved with daily procedures.  He is no longer employed at Searle.

An attempt was made to interview Dr. K. S. Rao, Monitor of Study P. T. #988S73 on 7-25-77.  We were referred to Dr. Rao's attorney, who refused permission for an interview (see Jerome Bressler's memo dated 7-27-77, Exh. #33).